Clinical Trials on Drug Toxicity Psychotropic Agents Psychostimulants

Total 310 results

Eagle Pharmaceuticals, Inc.

Terminated

Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)

Drug Toxicity Psychotropic Agents Psychostimulants

United States
Johns Hopkins University

Completed

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

Psilocybin | Therapeutic Uses | Psychotropic Drugs | Hallucinogens | Pharmacologic Actions | Central Nervous System Agents

United States
Janssen Korea, Ltd., Korea

Completed

A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

Mental Disorders | Schizophrenia | Tranquilizing Agents | Therapeutic Uses | Physiological Effects of Drugs | Psychotropic Drugs | Antipsychotic Agents
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy

Recovery | Drug Effect | Safety | Psychotropic Drugs | Anesthetics, Intravenous | Anesthetics

China
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/Organ

United States
Rush North Shore Medical Center

Completed

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/Organ

United States
Izmir Ataturk Training and Research Hospital

Not yet recruiting

The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients

Psychotropic Agents Causing Adverse Effects in Therapeutic Use | Anticholinergic Adverse Reaction | Anticholinergic Syndrome | Antiarrhythmic Drug Adverse Reaction | Antiparkinsonism Drugs Causing Adverse Effects in Therapeutic Use | Antispasmodic Adverse Reaction
NYU Langone Health
National Cancer Institute (NCI)

Completed

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/Organ

United States
Luye Pharma Group Ltd.

Completed

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

Mental Disorders | Psychotic Disorders | Mood Disorders | Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Molecular Mechanisms of Pharmacological Action | Tranquilizing Agents | Physiological Effects of Drugs | Psychotropic Drugs | Antipsychotic Agents | Neurotransmitter Agents | Central...

United States
Luye Pharma Group Ltd.

Completed

Relative Bioavailability of LY03010 Compared to Listed Drug

Mental Disorders | Psychotic Disorders | Mood Disorders | Schizophrenia | Molecular Mechanisms of Pharmacological Action | Tranquilizing Agents | Physiological Effects of Drugs | Psychotropic Drugs | Antipsychotic Agents | Central Nervous System Depressants | Neurotransmitter Agents | Schizophrenia Spectrum

United States
Fondation Lenval

Completed

Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs (M4P)

Psychotropic Drugs | Drug Resistance

France
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Leukemia | Drug/Agent Toxicity by Tissue/Organ

United States
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Breast Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
University of Arizona

Completed

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Breast Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
University of Illinois at Chicago

Unknown

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Head and Neck Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/Organ

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Unknown

Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T

Psychotropic Drugs Effects

United States
University of Tennessee

Completed

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Head and Neck Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

United States
University of Chicago
National Cancer Institute (NCI)

Completed

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Bladder Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Breast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/Organ

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Unknown

Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer

Lung Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
University of Florida

Unknown

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Lung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/Organ

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/Organ

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Completed

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/Organ

United States
Milton S. Hershey Medical Center

Completed

Diminish Chemotherapy Related Side Effects Through Patient Education (D-CRSE)

Chemotherapy Effect | Chemotherapeutic Toxicity | Chemotherapeutic Agent Toxicity

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Lung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

United States, Canada
European Organisation for Research and Treatment...

Terminated

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Head and Neck Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

Spain, France, Belgium, Italy, United Kingdom, Turkey
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Treatment of Acute Lymphoblastic Leukemia in Children

Leukemia | Drug/Agent Toxicity by Tissue/Organ

United States, Canada, Puerto Rico
Indiana University
Indiana University Melvin and Bren Simon Cancer Center

Completed

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Brain and Central Nervous System Tumors | Drug/Agent Toxicity by Tissue/Organ | Bone Marrow Suppression

United States
Queen Mary University of London

Completed

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Testicular Germ Cell Tumor | Drug/Agent Toxicity by Tissue/Organ

United Kingdom
Ligand Pharmaceuticals

Completed

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Lymphoma | Drug/Agent Toxicity by Tissue/Organ

United States
Wellstat Therapeutics

Completed

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Pancreatic Cancer | Drug/Agent Toxicity by Tissue/Organ

United States, Canada
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy

Leukemia | Drug/Agent Toxicity by Tissue/Organ

United States, Canada
Children's Hospital Los Angeles
National Cancer Institute (NCI)

Completed

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Diarrhea | Neuroblastoma | Drug/Agent Toxicity by Tissue/Organ

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Lung Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
Institut Claudius Regaud

Suspended

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Chemotherapeutic Agent Toxicity | Renal Toxicity

France
Assiut University

Not yet recruiting

Pattern of Acute Antipsychotic Drug- Toxicity in Children

Antipsychotic Drug- Toxicity
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Colorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation Enteritis

United States
Namik Kemal University

Recruiting

CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab

Nivolumab Related Toxicity

Turkey
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Ovarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor | Drug/Agent Toxicity by Tissue/Organ

United States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
University of Rochester

Completed

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/Organ

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Breast Cancer | Brain and Central Nervous System Tumors | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Drug/Agent Toxicity by Tissue/Organ
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Anemia | Lung Cancer | Neutropenia | Drug/Agent Toxicity by Tissue/Organ

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products

Physiological Effects of Drugs | Anti-Infective Agents | Vaccines | Immunologic Factors | Antiviral Agents

United States
Rush University Medical Center
National Cancer Institute (NCI)

Unknown

Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Myelodysplastic Syndromes | Leukemia | Neutropenia | Drug/Agent Toxicity by Tissue/Organ

United States
Universidad Nacional Andres Bello
Centro para la Prevención y Control del Cáncer (CECAN), Santiago, Chile

Recruiting

Telemonitoring Platforms and Chemotherapy-Associated Toxicity (DETECT)

Cancer | Chemotherapeutic Agent Toxicity

Chile
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Lymphoma | Thrombocytopenia | Brain and Central Nervous System Tumors | Drug/Agent Toxicity by Tissue/Organ

United States
Basilea Pharmaceutica

Completed

Effect of Ceftobiprole on Human Intestinal Microflora

Drug Resistance | Antimicrobial Agent | Cephalosporins
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Terminated

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Multiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/Organ

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Brain and Central Nervous System Tumors | Long-term Effects Secondary to Cancer Therapy in Children | Drug/Agent Toxicity by Tissue/Organ | Bone Marrow Suppression

United States

Clinical Trials on Drug Toxicity Psychotropic Agents Psychostimulants

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations